These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13622371)

  • 21. Retreatment of pulmonary tuberculosis. Experiences with various combinations of pyrazinamide, cycloserine, and kanamycin in patients excreting tubercle bacilli resistant to both streptomycin and isoniazid.
    HAAPANEN J; GILL R; RUSSELL WF; KASS I
    Am Rev Respir Dis; 1960 Dec; 82():843-52. PubMed ID: 13710174
    [No Abstract]   [Full Text] [Related]  

  • 22. Isoniazid treatment of early ambulant cases of pulmonary tuberculosis.
    KUO TL; CHANG JC; CHU TY
    Chin Med J; 1958 Apr; 76(4):401-5. PubMed ID: 13561460
    [No Abstract]   [Full Text] [Related]  

  • 23. Characteristics of mycobacterial populations found in the sputum of tuberculous patients after prolonged isoniazid therapy.
    PEIZER LR; CHAVES AD; WIDELOCK D
    Am Rev Respir Dis; 1960 Oct; 82():568-73. PubMed ID: 13733935
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 25. [Isoniazid and isoniazid combined with PAS in therapy of pulmonary tuberculosis; clinical and bacteriologic studies].
    HELWEG-LARSEN P; RASMUSSEN KN
    Ugeskr Laeger; 1954 Oct; 116(42):1493-8. PubMed ID: 13217102
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoniazid after five years.
    MUSCHENHEIM C
    Trans Am Clin Climatol Assoc; 1956-1957; 68():16-22; discussion 23-4. PubMed ID: 13486603
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ambulant chemotherapy of pulmonary tuberculosis].
    STEINHAEUSER F
    Tuberkulosearzt; 1957 Jan; 11(1):1-10. PubMed ID: 13409599
    [No Abstract]   [Full Text] [Related]  

  • 28. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A preliminary report on the safety and therapeutic activity of a salizid INH derivative.
    ROYE WE; EWART GE
    Dis Chest; 1958 Mar; 33(3):261-7. PubMed ID: 13512134
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemotherapy of pulmonary tuberculosis with nicoteben-compositum].
    KROBER KH
    Med Klin; 1958 Feb; 53(8):302-4. PubMed ID: 13540857
    [No Abstract]   [Full Text] [Related]  

  • 31. [Potassium iodide and methyl antigen in chronic pulmonary tuberculosis; variation of the number of radiologic and bacilloscopic improvements according to the method of treatment by streptomycin and isoniazid].
    NOUVION H; PELLIER G; GUILBAUD P; CHOVELON R; PLACE-VERGHNES A
    Rev Tuberc; 1953; 17(10-11):1071-3. PubMed ID: 13135254
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of a combined preparation of diphenyldimethylaminoethylbutanone hydrochloride and racemic 1-(p-hydroxyphenyl)-2-methylaminopropanol in pulmonary tuberculosis; functional clinical study].
    FODDAI A
    G Ital Della Tuberc; 1955; 9(4):232-6. PubMed ID: 13277834
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experiences with nicoteben treatment of 578 patients with pulmonary tuberculosis].
    HERTWIG B; VIRCHOW C
    Tuberkulosearzt; 1960 Aug; 14():530-42. PubMed ID: 13713810
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the effect of INH metabolism on the therapy of pulmonary tuberculosis].
    IWAINSKY H; KAUFFMANN GW; SIEGEL D; GERISCHER C
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1960; 122():324-32. PubMed ID: 14406169
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early results of isoniazid therapy as a function of the active blood level of isoniazid; study of 100 cases].
    VIVIEN JN; THIBIER R; GROSSET J; LEPEUPLE A
    Rev Tuberc; 1958; 22(2-3):208-22. PubMed ID: 13568460
    [No Abstract]   [Full Text] [Related]  

  • 36. Observations on cycloserineisoniazid in pulmonary tuberculosis.
    ACETO JN; COVERT DF
    Antibiotic Med Clin Ther (New York); 1960 Nov; 7():705-12. PubMed ID: 13681189
    [No Abstract]   [Full Text] [Related]  

  • 37. [Larusan therapy of pulmonary tuberculosis; preliminary communication].
    BUTKIN NG; SHELKOVKINA AV; NAZAROVA IB
    Probl Tuberk; 1956; 34(2):36-9. PubMed ID: 13335986
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined antibiotic therapy and chemotherapy of pulmonary tuberculosis with special reference to dihydrostreptomycin, paratebin and isoniazid].
    NIEMSCH H; SITT W
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 110(4):329-50. PubMed ID: 13140113
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of corticosteroids in combination with isonicotinic acid hydrazide in the treatment of advanced bilateral progressive cavitary pulmonary tuberculosis; second report with discussion.
    HANDLEY AE
    S Afr Med J; 1956 Dec; 30(52):1250-1. PubMed ID: 13391108
    [No Abstract]   [Full Text] [Related]  

  • 40. The rising incidence of isoniazid resistance: its clinical significance.
    REISS J; TOWNSEND SM
    Dis Chest; 1957 Sep; 32(3):274-9. PubMed ID: 13461770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.